About | Cardiology Conference 2025 | Heart Disease Congress Paris

Discounts are available until this weekend.

We are excited to have you join us for this premier event dedicated to exploring the future of cardiology and its impact on healthcare. Set to take place on September 11-12, 2025, in the vibrant city of Paris, France, this conference aims to unite professionals from across the globe to share insights, advancements, and best practices in the field of cardiology and heart diseases.

Our conference is designed to keep you at the forefront of emerging research and innovative practices. Cardiologist Stock Videos – 48,922 HD ... The program features
a broad spectrum of topics,includingadvanced diagnostics,innovationsin
cardiac care, interventional cardiology, and the integration ofdigital health technologies.
You will have the opportunity toengage with thoughtleaders who will present their
cutting-edge research and offer practical strategies for enhancing cardiovascular health.

We understand that navigating a conference can be both exciting and overwhelming, which is why we have curated a supportive and inclusive environment. Our dedicated team is here to assist you with any questions or needs, ensuring you make the most of the resources and opportunities available. At Cardiology 2025, we emphasize the importance of collaboration and networking in advancing the field. We encourage you to connect with fellow attendees, exchange ideas, and leave inspired and equipped with new knowledge and connections.

Why to Attend

Participating in the 6th International Conference on Cardiology and Heart Diseases in Paris provides a unique chance to engage with the latest developments and innovations in the field. The conference offers a comprehensive overview of current research, from advances in cardiac imaging and surgery to novel therapeutic strategies and preventive cardiology. By connecting with leading professionals and peers, you can build valuable relationships, gain new insights, and explore potential research collaborations. Presenting your work will enable you to share your findings with a global audience and receive meaningful feedback. Attending this conference not only enhances your professional growth but also contributes to the collective effort to combat heart diseases worldwide.

Who Will Be the Participants?

SESSIONS AND TRACKS:

Track 1: Clinical Cardiology

Clinical Cardiology focuses on the practical diagnosis and management of both common and complex cardiovascular diseases. It emphasizes comprehensive patient evaluation including history, physical examination, and risk stratification using evidence-based tools. The track covers pharmacologic and non-pharmacologic treatment strategies to optimize patient outcomes. Discussions include management of ischemic heart disease, heart failure, hypertension, and arrhythmias within everyday clinical settings. Emerging diagnostic techniques, clinical guidelines, and multidisciplinary care approaches are highlighted to improve cardiovascular health. This track is essential for cardiologists, internists, and healthcare professionals aiming to enhance decision-making in routine cardiology practice.

Track 2: Interventional Cardiology

Interventional Cardiology explores catheter-based treatments for cardiovascular conditions, including angioplasty, stenting, and trans catheter valve repair or replacement. This track highlights advances in minimally invasive techniques that reduce procedural risks and improve recovery times. It focuses on innovations in device technology, imaging guidance, and procedural strategies to optimize patient outcomes. Post-procedural care, complication management, and long-term follow-up are also emphasized. Emerging therapies for complex lesions such as chronic total occlusions and structural heart disease interventions are discussed. Interventional cardiologists, surgeons, and allied professionals benefit from insights into cutting-edge catheter interventions and evolving clinical protocols.

Track 3: Pediatric Cardiology

Pediatric Cardiology addresses the diagnosis, treatment, and long-term management of congenital and acquired heart diseases in neonates, children, and adolescents. Topics include cardiac malformations, arrhythmias, cardiomyopathies, and heart failure specific to pediatric populations. This track emphasizes surgical and catheter-based interventions tailored for young patients, alongside non-invasive diagnostic advances. Long-term follow-up strategies focusing on growth, development, and psychosocial support are discussed. Special attention is given to managing complex cases like single ventricle physiology and pulmonary hypertension. Pediatric cardiologists, cardiac surgeons, and healthcare providers learn comprehensive approaches to optimize care and improve quality of life in pediatric heart disease.

Track 4: Cardiac Surgery

The Cardiac Surgery track focuses on the latest advances in surgical techniques for treating heart diseases, including coronary artery bypass grafting, valve repair or replacement, and heart transplantation. It highlights minimally invasive and robotic-assisted approaches aimed at reducing operative trauma and enhancing recovery. Discussions include patient selection, perioperative management, and innovations in cardiopulmonary bypass and myocardial protection. Postoperative care, including enhanced recovery protocols and complication prevention, is emphasized. This track is designed for cardiac surgeons, anesthesiologists, and perioperative teams, offering insights into improving surgical outcomes and advancing heart surgery technologies.

Track 5: Heart Failure & Cardiomyopathies

This track explores the pathophysiology, diagnosis, and management of heart failure and myocardial diseases, including dilated, hypertrophic, and restrictive cardiomyopathies. It covers pharmacological treatments such as neurohormonal blockade, device therapies including implantable defibrillators and cardiac resynchronization, and advanced options like mechanical circulatory support and transplantation. The role of biomarkers, imaging, and genetic testing in diagnosis and prognosis is discussed. Emphasis is placed on optimizing quality of life, reducing hospitalizations, and improving survival. Heart failure specialists, cardiologists, and researchers benefit from current therapeutic advances and emerging clinical trials shaping future heart failure care.

Track 6: Arrhythmias & Electrophysiology

Arrhythmias & Electrophysiology focuses on the diagnosis and treatment of abnormal heart rhythms. The track covers mechanisms underlying atrial fibrillation, ventricular tachycardia, and bradyarrhythmias. It highlights catheter ablation techniques, device therapy such as pacemakers and implantable cardioverter defibrillators (ICDs), and advancements in cardiac mapping and remote monitoring technologies. Strategies for risk stratification and prevention of sudden cardiac death are explored. The role of genetic and molecular insights in arrhythmia management is discussed. Electrophysiologists and cardiologists gain knowledge on integrating novel diagnostics and therapies to improve patient safety and outcomes.

Track 7: Preventive Cardiology & Rehabilitation

Preventive Cardiology & Rehabilitation emphasizes early identification and modification of cardiovascular risk factors to prevent disease onset and progression. It includes lifestyle interventions such as diet, exercise, smoking cessation, and stress management. This track covers pharmacological prevention strategies for hypertension, hyperlipidemia, and diabetes. Post-cardiac event rehabilitation focuses on multidisciplinary care involving physical therapy, medication adherence, psychological support, and risk factor control to improve recovery and reduce recurrence. Emerging digital health tools and community-based programs are also reviewed. Cardiologists, primary care providers, and rehabilitation specialists benefit from comprehensive approaches to enhance cardiovascular wellness and patient quality of life.

Track 8: Hypertension and Vascular Health

This track delves into hypertension’s effects on cardiovascular and target organs including the brain, kidneys, and vasculature. It covers pathophysiology, diagnosis, and evidence-based treatment strategies combining lifestyle modifications and pharmacologic agents such as ACE inhibitors, ARBs, calcium channel blockers, and diuretics. The track discusses resistant hypertension, secondary causes, and novel antihypertensive therapies. Vascular health topics include endothelial dysfunction, arterial stiffness, and prevention of complications like stroke and renal impairment. Interdisciplinary approaches involving cardiologists, nephrologists, and primary care providers aim to optimize blood pressure control and vascular protection.

Track 9: Coronary Artery Disease (CAD)

Coronary Artery Disease track focuses on the pathogenesis, diagnosis, and management of atherosclerotic heart disease. It includes medical therapy such as antiplatelet, statins, and lifestyle interventions alongside interventional procedures like percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). Emphasis is placed on acute coronary syndromes management, secondary prevention, and risk factor modification. Advances in imaging and biomarkers to improve risk stratification and guide treatment decisions are explored. Cardiologists, intervention lists, and primary care physicians are equipped with updated evidence-based practices to reduce morbidity and mortality from CAD.

Track 10: Cardiac Imaging & Diagnostics

This track highlights innovations in non-invasive and invasive cardiac imaging modalities, including echocardiography, cardiac MRI, CT angiography, and nuclear imaging. It focuses on their role in early detection, diagnosis, and monitoring of cardiovascular diseases. Techniques such as 3D imaging, strain imaging, and perfusion studies enhance diagnostic accuracy. Emerging imaging biomarkers and AI integration in image interpretation are discussed. Radiologists, cardiologists, and technologists learn to optimize imaging protocols for personalized patient care, enabling precise evaluation of structural, functional, and ischemic heart conditions.

Track 11: Cardio-Oncology

Cardio-Oncology addresses cardiovascular complications arising from cancer therapies such as chemotherapy, radiotherapy, and immunotherapy. The track explores mechanisms of cardiotoxicity, including heart failure, arrhythmias, and vascular damage. Strategies for risk assessment, early detection, and prevention of cardiac side effects are emphasized. Collaborative care models integrating oncologists and cardiologists improve patient outcomes. Advances in biomarkers, imaging, and novel protective agents are reviewed. This multidisciplinary track is essential for managing the growing population of cancer survivors with cardiovascular risks.

Track 12: Diabetes and Cardiovascular Risk

This track investigates the intricate relationship between diabetes mellitus and cardiovascular disease. It covers pathophysiological mechanisms linking hyperglycemia, insulin resistance, and vascular dysfunction. Management strategies include glucose control, antihypertensive therapy, lipid management, and antiplatelet agents to reduce cardiovascular morbidity and mortality. Emerging therapies like SGLT2 inhibitors and GLP-1 receptor agonists are highlighted for their cardio protective effects. The track also addresses patient education and integrated care models. Endocrinologists, cardiologists, and primary care providers gain insights into optimizing cardiovascular outcomes in diabetic patients.

Track 13: Women’s Heart Health

Women’s Heart Health focuses on gender-specific cardiovascular risk factors, symptoms, and disease presentation unique to women. It addresses the impact of hormonal changes, pregnancy-related conditions, and psychosocial factors on heart disease. Prevention and treatment strategies are tailored to address disparities in diagnosis and outcomes. Topics include ischemic heart disease, microvascular dysfunction, and autoimmune-related cardiovascular conditions. This track raises awareness of sex-specific research and encourages personalized care approaches. Cardiologists, gynecologists, and primary care providers benefit from understanding how to optimize cardiovascular health for female patients.

Track 14: Cardiovascular Pharmacology

This track explores current and emerging cardiovascular pharmacotherapies, including antihypertensive, anticoagulants, antiplatelet, lipid-lowering agents, and novel drugs targeting heart failure and arrhythmias. It emphasizes mechanisms of action, clinical efficacy, safety profiles, and updates from recent clinical trials. Discussions include drug-drug interactions, personalized medicine approaches, and strategies to improve medication adherence. Pharmacologists, cardiologists, and healthcare professionals gain critical knowledge to optimize therapeutic regimens, enhance patient outcomes, and incorporate novel agents into clinical practice.

Track 15: Regenerative Cardiology & Stem Cells

Regenerative Cardiology focuses on innovative therapies aimed at repairing and regenerating damaged myocardial tissue using stem cells, tissue engineering, and gene therapy. The track covers preclinical studies and clinical trials exploring mesenchymal stem cells, induced pluripotent stem cells, and biomaterials. It addresses challenges in cell delivery, survival, and integration. Potential applications in ischemic heart disease, cardiomyopathies, and heart failure are discussed. Researchers and clinicians gain insights into the future of cardiac repair and the evolving landscape of regenerative medicine.

Track 16: Sports Cardiology

Sports Cardiology centers on cardiovascular evaluation and care of athletes, emphasizing prevention, early detection, and management of cardiac conditions that may lead to sudden cardiac death. Topics include exercise physiology, screening protocols, and risk stratification for competitive sports participation. The track discusses arrhythmias, cardiomyopathies, and congenital heart disease in athletes. Guidance on safe training, performance optimization, and return-to-play decisions is provided. Sports physicians, cardiologists, and trainers gain knowledge to promote cardiovascular safety and enhance athletic performance.

Track 17: Cardiac Devices and Implantables

This track covers advances in implantable cardiac devices such as pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. It focuses on patient selection criteria, device programming, and troubleshooting. Emerging technologies in wearable monitors, remote device monitoring, and leadless pacemakers are reviewed. Discussions include complication management, infection prevention, and optimizing device longevity. Cardiologists, electrophysiologists, and device specialists gain expertise in leveraging technology to improve arrhythmia management and heart failure outcomes.

Track 18: Acute Coronary Syndromes (ACS)

The ACS track focuses on the emergency management of unstable angina, NSTEMI, and STEMI. It covers early recognition, risk stratification, reperfusion therapies including PCI and thrombolysis, and adjunctive pharmacologic treatment. Post-acute care involves secondary prevention, cardiac rehabilitation, and lifestyle modifications. Emerging protocols and quality improvement initiatives to reduce door-to-balloon time and improve survival rates are discussed. Emergency physicians, cardiologists, and critical care teams learn best practices to optimize acute coronary care and minimize complications.

Track 19: Artificial Intelligence in Cardiology

This track explores applications of artificial intelligence (AI) and machine learning in cardiology, including enhanced imaging analysis, predictive analytics, risk stratification, and personalized treatment planning. AI-driven tools improve diagnostic accuracy, workflow efficiency, and patient monitoring. Topics include natural language processing, wearable sensors, and integration with electronic health records. Ethical considerations and future potential of AI in research and clinical practice are examined. Cardiologists, data scientists, and healthcare innovators gain insights into leveraging AI to transform cardiovascular care delivery.

Track 20: Personalized Cardiology and Precision Medicine

Personalized Cardiology emphasizes individualized cardiovascular care through genetic profiling, biomarker analysis, and advanced diagnostics. The track explores how precision medicine tailors therapeutic strategies based on patient-specific molecular and genetic information. It covers pharmacogenomics, targeted therapies, and risk prediction models to optimize efficacy and minimize adverse effects. Integration of multi-omics data and digital health technologies supports real-time personalized interventions. Clinicians and researchers gain knowledge on implementing precision cardiology to improve.

MARKET ANALYSIS REPORT OF CARDIOLOGY AND HEART DISEASES

The global cardiology and heart diseases market is experiencing robust growth, projected to reach $550 billion in 2024 with a compound annual growth rate of 6–7% over the next five years. This expansion is fueled by technological advancements, an aging population, and the increasing prevalence of sedentary lifestyles and non-communicable diseases. Key market segments such as interventional cardiology, cardiac rhythm management devices, minimally invasive procedures, and diagnostic technologies are seeing rapid innovation. Digital health tools including wearable ECG monitors and AI-powered diagnostics are revolutionizing cardiovascular care, improving patient outcomes, and expanding remote access through tele cardiology. Regionally, North America dominates the market due to strong healthcare infrastructure and R&D investments, while Europe benefits from proactive public health policies and aging demographics. The Asia-Pacific region is emerging rapidly, particularly in China, India, and Japan, where economic development and urbanization are driving demand. Meanwhile, Latin America and the Middle East & Africa are witnessing increasing awareness and investment in cardiac healthcare. Major industry players like Medtronic, Abbott, Boston Scientific, GE Healthcare, and Philips are spearheading advancements through innovation and strategic collaboration. As the market evolves with trends such as AI integration, personalized medicine, and robotic procedures, the 6th International Conference on Cardiology and Heart Diseases, scheduled for September 11-12, 2025, in Paris, France, stands as a critical platform for global experts, researchers, and clinicians to discuss groundbreaking developments and collaborative strategies in cardiovascular science and patient care. This robust market backdrop underscores the significance of the 6th International Conference on Cardiology and Heart Diseases, scheduled for September 11-12, 2025, in Paris, France, which aims to bring together experts, researchers, and industry professionals to discuss innovations and breakthroughs in cardiovascular science and clinical practice.

AI In Cardiology Market Growth Analysis ...

Visa Trip Advisor

Planning a trip to Paris? Join our Cardiology 2025 Conference!
Need help with your visa?

To assist participants with their visa applications, we provide the following support documents:

Official Letter of Invitation
Official Letter of Abstract Acceptance
Payment Receipt

Important Points:

The Official Letter of Invitation will be issued only after successful registration and payment for the conference.
Visa Letters can only be issued for individuals accepted to attend the conference.
To arrange for a Visa Letter, please contact our Program Manager, Ms. Jennifer Anne, at scientificmeetings@conferencesinternational.org.

To request your Visa Letter, please provide:

Your full name as it appears on your passport
A scanned copy of your passport (to verify passport number and date of birth)
The Abstract Acceptance Letter (for presenters)

Payment Options:

Payment Gateway/Stripe
Bank Transfer

Need help with registration?
Contact Ms. Jennifer Anne at scientificmeetings@conferencesinternational.org. The Cardiology 2025 team will provide you with an invoice to facilitate a bank transfer.

Advantages of Participation

Participation Options

Cardiology 2025 offers various ways to engage, categorized into Academic, Student, and Business sections:

Keynote Speaker: 45–50 minutes
Oral Presentation: 25–30 minutes (individual presenters only)
Workshop: 45–50 minutes (multiple presenters allowed)
Special Session: 45–50 minutes (multiple presenters allowed)
Symposium: Over 45 minutes (multiple presenters allowed)
Delegate Registration: Access to all sessions with full benefits
Poster Presenter: Present a poster and access delegate benefits
Remote Attendance: Participate via virtual mode, video presentation, or e-poster
Exhibitor: Showcase products through various booth sizes
Media Partner, Sponsor, Collaborator

Benefits of Attending the Conference

Earn CPD credits along with a participation certificate
Gain global visibility via Speaker and Abstract pages indexed by Google
Access our Library of Abstracts with 30,000+ monthly visitors
Engage in interactive sessions and team-based presentations
Network with leading experts in Cardiology and Cardiovascular Research
Compete for the Young Scientist Award and Best Poster certificates
One-on-one discussions with renowned speakers
Attend high-impact Keynote talks by global cardiovascular leaders

Benefits for Speakers

All accepted abstracts published in relevant journals
CPD credits and official certification
International visibility for research
Professional development and collaboration opportunities
Access to the latest breakthroughs in cardiology
Global networking with like-minded professionals
Abstract books and promotional flyers (reach: 1 million+ views)
Opportunities to explore beyond your primary research focus

Benefits for Delegates

Enhance your knowledge in cardiology and heart health
Rejuvenate your passion for innovation in medicine
Support cutting-edge solutions for cardiovascular challenges
Build networks with academic and clinical leaders

Benefits for Sponsors

Global exposure in cardiovascular health markets
Product and service visibility to a targeted audience
Qualified lead generation and business development
Opportunities for strategic collaborations and feedback
Benchmark with top industry innovators

Benefits for Collaborators

Access to a high-traffic platform with global visibility
Long-term partnerships and expanded brand reach
Representation in promotional content sent to hospitals, universities, and industry professionals
Engage with key delegates and increase organizational visibility

Sponsor Packages

Elite Sponsor Benefits

Sponsor 10 Poster Presentation Awards
3 Corporate workshops (with A/V support)
2 Complimentary booths (3x3 sqm each, premium locations)
4 Complimentary conference registrations
Logo on homepage, sponsorship page, and partner journal homepage
Full-page color ad in the conference program (excl. covers)
3 Inserts in delegate bags
1 Post-event email promotion (content subject to approval)
Promotion on all social media platforms
20% discount on next year’s sponsorship

Gold Sponsor Benefits

Sponsor 5 Poster Presentation Awards
2 Corporate workshops (A/V & catering included)
1 Complimentary booth (3x3 sqm)
3 Complimentary registrations
Logo on homepage and sponsorship page
Full-page ad in the program (excl. covers)
2 Inserts in delegate bags
Social media promotion
15% discount on next year’s sponsorship

Silver Sponsor Benefits

Sponsor 3 Poster Presentation Awards
2 Complimentary registrations
1 Workshop slot (A/V & catering included)
1 Complimentary booth (3x3 sqm)
Logo on sponsorship page
Full-page ad in the program
1 Insert in delegate bags
Priority sponsorship item access
Social media promotion
10% discount on next year’s sponsorship

Exhibition Sponsorship Benefits

Ideal venue for collaborations and showcasing innovations
High engagement with decision-makers (89% are purchase influencers)
80% booth revisit rate during the event
Rich feedback and lead generation from attendees
Business-to-business networking
1 Poster Presentation Award sponsorship opportunity
1 Complimentary registration
Custom booth setup (3x3 sqm)
Logo placement on sponsorship page
A4 ad in the program/abstract book
Company leaflet/inserts in delegate bags
Online and social media promotion
5% discount on future sponsorships
Brand visibility through global marketing channels
Brochure distribution, logo at ceremonies, and press releases

Abstracts enquiry

Registration enquiry

Contact Enquiry

Phone

WhatsApp

Useful Links

News

Newsletter